You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Hematologic Cancers

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Hematologic Tumors Trial in Spain, United States (CC-90002, Rituximab)

Completed
  • Hematologic Neoplasms
  • Scottsdale, Arizona
  • +12 more
Aug 10, 2021

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Duarte, California
  • +8 more
Jan 11, 2023

Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

Recruiting
  • Neoplasms
  • Birmingham, Alabama
  • +62 more
Jan 19, 2023

Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 7, 2022

Advanced Solid Tumors and Hematological Malignancies Trial (TQB2928 Injection)

Not yet recruiting
  • Advanced Solid Tumors and Hematological Malignancies
  • TQB2928 Injection
  • (no location specified)
Apr 21, 2021

Advanced Solid Cancers, Hematologic Cancers Trial in New York, San Antonio, Toronto (SRF231)

Completed
  • Advanced Solid Cancers
  • Hematologic Cancers
  • New York, New York
  • +2 more
Oct 19, 2020

Advanced Cancers, Hematologic Disorder, Solid Tumors Trial in Houston (drug, behavioral, device, other)

Completed
Has Results
  • Advanced Cancers
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2021

Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Sep 5, 2023

Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)

Not yet recruiting
  • Colon Cancer
  • Immunotherapy
  • Chongqing, China
    Daping hospital
Apr 16, 2023

Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)

Not yet recruiting
  • Gastrointestinal Cancer
  • (no location specified)
Oct 2, 2023

Cancer Gi Trial (ERCP alone, ERCP +ProEUS-GE)

Not yet recruiting
  • Cancer Gi
  • ERCP alone
  • ERCP +ProEUS-GE
  • (no location specified)
Aug 15, 2023

Hepatobiliary Cancer, Liver Cancer Trial (Zimberelimab, Domvanalimab)

Not yet recruiting
  • Hepatobiliary Cancer
  • Liver Cancer
  • (no location specified)
Feb 2, 2023

Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Liver Cancers
  • +4 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Paris, France
    Tredaniel
May 18, 2022

Advanced Solid Tumor Trial (NXP900)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 15, 2023

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)

Not yet recruiting
  • Lung Cancer
  • Gastro-intestinal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
May 9, 2023

Advanced Cancer Trial in Chengdu, Hangzhou (TQB2223 injection+ Penpulimab Injection)

Recruiting
  • Advanced Cancer
  • TQB2223 injection+ Penpulimab Injection
  • Chengdu, Sichuan, China
  • +1 more
Jun 7, 2023

Advanced Cancer Trial in San Diego (personalized vaccine, Pembrolizumab)

Active, not recruiting
  • Advanced Cancer
  • San Diego, California
    UCSD Medical Center
Sep 20, 2022

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

Advanced Cancer Trial in Guangzhou (TQB2102 injection)

Not yet recruiting
  • Advanced Cancer
  • TQB2102 injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 23, 2023

Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

Not yet recruiting
  • Advanced Systemic Mastocytosis
  • (no location specified)
Nov 2, 2022